FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3137711059> ?p ?o ?g. }

• W3137711059 endingPage "114516" @default.
• W3137711059 startingPage "114516" @default.
• W3137711059 abstract "The overexpression of the human ATP-binding cassette (ABC) drug transporter ABCB1 (P-glycoprotein, P-gp) or ABCG2 (breast cancer resistance protein, BCRP) in cancer cells often contributes significantly to the development of multidrug resistance (MDR) in cancer patients. Previous reports have demonstrated that some epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) could modulate the activity of ABCB1 and/or ABCG2 in human cancer cells, whereas some EGFR TKIs are transport substrates of these transporters. Almonertinib (HS-10296) is a promising, orally available third-generation EGFR TKI for the treatment of EGFR T790M mutation-positive non-small cell lung cancer (NSCLC) in patients who have progressed on or after other EGFR TKI therapies. Additional clinical trials are currently in progress to study almonertinib as monotherapy and in combination with other agents in patients with NSCLC. In the present work, we found that neither ABCB1 nor ABCG2 confers significant resistance to almonertinib. More importantly, we discovered that almonertinib was able to reverse MDR mediated by ABCB1, but not ABCG2, in multidrug-resistant cancer cells at submicromolar concentrations by inhibiting the drug transport activity of ABCB1 without affecting its expression level. These findings are further supported by in silico docking of almonertinib in the drug-binding pocket of ABCB1. In summary, our study revealed an additional activity of almonertinib to re-sensitize ABCB1-overexpressing multidrug-resistant cancer cells to conventional chemotherapeutic drugs, which may be beneficial for cancer patients and warrant further investigation." @default.
• W3137711059 created "2021-03-29" @default.
• W3137711059 creator A5002885162 @default.
• W3137711059 creator A5013121343 @default.
• W3137711059 creator A5015196276 @default.
• W3137711059 creator A5015935065 @default.
• W3137711059 creator A5057841332 @default.
• W3137711059 creator A5075704903 @default.
• W3137711059 creator A5081938413 @default.
• W3137711059 creator A5082132632 @default.
• W3137711059 date "2021-06-01" @default.
• W3137711059 modified "2023-10-16" @default.
• W3137711059 title "The third-generation EGFR inhibitor almonertinib (HS-10296) resensitizes ABCB1-overexpressing multidrug-resistant cancer cells to chemotherapeutic drugs" @default.
• W3137711059 cites W124635973 @default.
• W3137711059 cites W1578072993 @default.
• W3137711059 cites W175263069 @default.
• W3137711059 cites W1905469811 @default.
• W3137711059 cites W192621565 @default.
• W3137711059 cites W1968172974 @default.
• W3137711059 cites W1970238406 @default.
• W3137711059 cites W1971950332 @default.
• W3137711059 cites W1978316298 @default.
• W3137711059 cites W1981078630 @default.
• W3137711059 cites W1983688434 @default.
• W3137711059 cites W1989502449 @default.
• W3137711059 cites W1992069798 @default.
• W3137711059 cites W1997241897 @default.
• W3137711059 cites W2000780867 @default.
• W3137711059 cites W2006960455 @default.
• W3137711059 cites W2018007736 @default.
• W3137711059 cites W2031240327 @default.
• W3137711059 cites W2032613216 @default.
• W3137711059 cites W2043320183 @default.
• W3137711059 cites W2055904567 @default.
• W3137711059 cites W2058804306 @default.
• W3137711059 cites W2059930172 @default.
• W3137711059 cites W2061773900 @default.
• W3137711059 cites W2064067180 @default.
• W3137711059 cites W2069382823 @default.
• W3137711059 cites W2072517578 @default.
• W3137711059 cites W2074232172 @default.
• W3137711059 cites W2081538957 @default.
• W3137711059 cites W2082843436 @default.
• W3137711059 cites W2085355316 @default.
• W3137711059 cites W2091371557 @default.
• W3137711059 cites W2097897956 @default.
• W3137711059 cites W2098064809 @default.
• W3137711059 cites W2100049008 @default.
• W3137711059 cites W2103246933 @default.
• W3137711059 cites W2103354871 @default.
• W3137711059 cites W2106483532 @default.
• W3137711059 cites W2108349673 @default.
• W3137711059 cites W2110444464 @default.
• W3137711059 cites W2112875577 @default.
• W3137711059 cites W2113791211 @default.
• W3137711059 cites W2116219814 @default.
• W3137711059 cites W2118443127 @default.
• W3137711059 cites W2134967712 @default.
• W3137711059 cites W2137632859 @default.
• W3137711059 cites W2143340316 @default.
• W3137711059 cites W2146228312 @default.
• W3137711059 cites W2147930289 @default.
• W3137711059 cites W2148146955 @default.
• W3137711059 cites W2149372899 @default.
• W3137711059 cites W2150497755 @default.
• W3137711059 cites W2158134441 @default.
• W3137711059 cites W2262265312 @default.
• W3137711059 cites W2321387150 @default.
• W3137711059 cites W2376953009 @default.
• W3137711059 cites W2414957002 @default.
• W3137711059 cites W2578736186 @default.
• W3137711059 cites W2594574304 @default.
• W3137711059 cites W2753365194 @default.
• W3137711059 cites W2782736845 @default.
• W3137711059 cites W2791331573 @default.
• W3137711059 cites W2795708883 @default.
• W3137711059 cites W2796552195 @default.
• W3137711059 cites W2808357871 @default.
• W3137711059 cites W2883516319 @default.
• W3137711059 cites W2884094759 @default.
• W3137711059 cites W2913173637 @default.
• W3137711059 cites W2914671825 @default.
• W3137711059 cites W2918409259 @default.
• W3137711059 cites W2944437316 @default.
• W3137711059 cites W2946983602 @default.
• W3137711059 cites W2948328122 @default.
• W3137711059 cites W2954349648 @default.
• W3137711059 cites W2981598927 @default.
• W3137711059 cites W3000175733 @default.
• W3137711059 cites W3001778677 @default.
• W3137711059 cites W3002485806 @default.
• W3137711059 cites W3029044317 @default.
• W3137711059 cites W3083988862 @default.
• W3137711059 cites W3113018316 @default.
• W3137711059 cites W4293003482 @default.
• W3137711059 cites W53566393 @default.
• W3137711059 doi "https://doi.org/10.1016/j.bcp.2021.114516" @default.
• W3137711059 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8291035" @default.

• next